CLOs on the Move

General Catalyst

www.generalcatalyst.com

 
General Catalyst is a venture capital firm that makes early-stage and transformational investments. General Catalyst backs exceptional entrepreneurs who are building innovative technology companies and market leading businesses, including Airbnb, BigCommerce, ClassPass, Datalogix, Datto, Demandware, Gusto (fka ZenPayroll), The Honest Company, HubSpot, KAYAK, Oscar, Snap, Stripe, and Warby Parker. The General Catalyst team leverages its broad experience to help founders build extraordinary companies. General Catalyst has offices in Cambridge, MA, Palo Alto, CA and New York City.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Anthony Dell
 Chief Compliance Officer Profile
Alexis Weiss
 Associate General Counsel Profile

Similar Companies

New York City Investment Fund, LLC

New York City Investment Fund, LLC is one of the leading companies in the Financial Services sector.

DriveWealth

DriveWealth is a financial technology firm pioneering embedded finance, fractional investing in US equities, and API-driven brokerage infrastructure. We`ve built patent-pending technology to fractionalize US equities and were the first to receive a license to do so in 2015. We help banks, fintechs, RIAs, and global brands build investing experiences in 153 countries. Some of our partners are Revolut, Hatch, MoneyLion, Stake, and Avenue.

John Wornall House Museum Inc

John Wornall House Museum Inc is a Kansas City, MO-based company in the Financial Services sector.

Wambia Capital

Wambia Capital LLC is a Boyds, MD-based company in the Financial Services sector.

BullFrog AI

BullFrog AI is an investor-backed company determined to become the undisputed leader in precision medicine. Our mission is to find the link between therapies and patients, and improve their lives. Using our proprietary technology platform, we aim to predict which patients will benefit from which medications, effectively improving clinical outcomes and eliminating the problem of trial-and-error prescriptions. We have an exceptional team of life science industry leaders, AI technologists, scientists, physicians and advisors determined to help BullFrog AI revolutionize drug development. Through our partnership with one of the most prestigious research institutions in the world, we take pride in technology innovation by staying on the cutting edge of AI.